200 related articles for article (PubMed ID: 37834217)
1. Metabolomic Signatures of Alzheimer's Disease Indicate Brain Region-Specific Neurodegenerative Progression.
Ambeskovic M; Hopkins G; Hoover T; Joseph JT; Montina T; Metz GAS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834217
[TBL] [Abstract][Full Text] [Related]
2. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
4. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
[TBL] [Abstract][Full Text] [Related]
6. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.
Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP
J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.
Song T; Song X; Zhu C; Patrick R; Skurla M; Santangelo I; Green M; Harper D; Ren B; Forester BP; Öngür D; Du F
Ageing Res Rev; 2021 Dec; 72():101503. PubMed ID: 34751136
[TBL] [Abstract][Full Text] [Related]
8. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
9. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
Snytnikova O; Telegina D; Savina E; Tsentalovich Y; Kolosova N
J Alzheimers Dis; 2024; 99(s2):S327-S344. PubMed ID: 37980669
[TBL] [Abstract][Full Text] [Related]
11. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
12. Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
Dong Y; Brewer GJ
J Alzheimers Dis; 2019; 71(1):119-140. PubMed ID: 31356210
[TBL] [Abstract][Full Text] [Related]
13. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
[TBL] [Abstract][Full Text] [Related]
14. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer's Disease.
Reveglia P; Paolillo C; Angiolillo A; Ferretti G; Angelico R; Sirabella R; Corso G; Matrone C; Di Costanzo A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298687
[TBL] [Abstract][Full Text] [Related]
15. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
16. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
[TBL] [Abstract][Full Text] [Related]
17. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
[TBL] [Abstract][Full Text] [Related]
19. Metabolic disorder in Alzheimer's disease.
Poddar MK; Banerjee S; Chakraborty A; Dutta D
Metab Brain Dis; 2021 Jun; 36(5):781-813. PubMed ID: 33638805
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
